Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Times of India
The Times of India
Business
TIMESOFINDIA.COM

UNCOVERED: Concord biotech ipo all you need to know - Caught on Camera

NEW DELHI: Concord Biotech, backed by Rare Enterprises, has announced the price band for its initial public offering (IPO) at Rs 705-741 per share, aiming to raise Rs 1,550 crore.

The IPO will be open for public subscription from August 4 to August 8, as per the company's statement. The offering consists of 2.09 crore equity shares, offered entirely through an offer-for-sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by private equity firm Quadria Capital. The eligible employees have also been given a reservation for subscriptions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.